Revenue
No reported data
Acurx Pharmaceuticals, Inc. (ACXP)
Price—Loading quote
Net income
2020
2021
2022
2023
2024
2025
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Research & development | $1.8M | $5.4M | $6.0M | $4.8M | $2.0M | $2.2M |
| Operating expenses | $8.1M | $14.1M | $14.6M | $12.1M | $12.8M | $4.6M |
| Operating income | −$8.1M | −$14.1M | — | — | — | — |
| Net income | −$8.0M | −$14.1M | −$14.6M | −$12.1M | −$12.7M | −$4.6M |
| Basic EPSper diluted share | -$5.32 | -$17.45 | -$1.15 | -$1.12 | -$1.49 | -$0.74 |
| Diluted EPSper diluted share | -$5.32 | -$17.45 | -$1.15 | -$1.12 | -$1.49 | -$0.74 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jan 6, 2025Form 4 | Scodari Joseph CDirector | BuyCommon Stock | 24.6K | $1.02 | $25.1K | 27.7K |
| Jan 6, 2025Form 4 | Scodari Joseph CDirector | BuyWarrants for Common Stock · derivative | 24.6K | $0.00 | $0.00 | 24.6K |
| Jan 6, 2025Form 4 | Sailer CarlDirector | BuyCommon Stock | 24.6K | $1.02 | $25.1K | 137.2K |
| Jan 6, 2025Form 4 | Sailer CarlDirector | BuyWarrants for Common Stock · derivative | 24.6K | $0.00 | $0.00 | 24.6K |
| Jan 6, 2025Form 4 | LUCI DAVID PPresident and CEO | BuyCommon Stock | 49.3K | $1.02 | $50.2K | 1.10M |